Literature DB >> 25126391

Inflammation in diabetic kidney disease.

Patricia M García-García1, María A Getino-Melián1, Virginia Domínguez-Pimentel1, Juan F Navarro-González1.   

Abstract

Diabetes mellitus entails significant health problems worldwide. The pathogenesis of diabetes is multifactorial, resulting from interactions of both genetic and environmental factors that trigger a complex network of pathophysiological events, with metabolic and hemodynamic alterations. In this context, inflammation has emerged as a key pathophysiology mechanism. New pathogenic pathways will provide targets for prevention or future treatments. This review will focus on the implications of inflammation in diabetes mellitus, with special attention to inflammatory cytokines.

Entities:  

Keywords:  Cytokines; Diabetes; Diabetic kidney disease; Diabetic nephropathy; Inflammation; Oxidative stress

Year:  2014        PMID: 25126391      PMCID: PMC4127580          DOI: 10.4239/wjd.v5.i4.431

Source DB:  PubMed          Journal:  World J Diabetes        ISSN: 1948-9358


  147 in total

Review 1.  Hyperglycemia and intestinal and renal glucose transport: implications for diabetic renal injury.

Authors:  E S Debnam; R J Unwin
Journal:  Kidney Int       Date:  1996-10       Impact factor: 10.612

2.  IFNgamma induces functional chemokine receptor expression in human mesangial cells.

Authors:  M Schwarz; M Wahl; K Resch; H H Radeke
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

3.  Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats.

Authors:  C Sassy-Prigent; D Heudes; C Mandet; M F Bélair; O Michel; B Perdereau; J Bariéty; P Bruneval
Journal:  Diabetes       Date:  2000-03       Impact factor: 9.461

4.  Activation of nuclear factor-kappaB in cultured endothelial cells by increased glucose concentration: prevention by calphostin C.

Authors:  G M Pieper
Journal:  J Cardiovasc Pharmacol       Date:  1997-10       Impact factor: 3.105

5.  Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy.

Authors:  Shinsuke Kiritoshi; Takeshi Nishikawa; Kazuhiro Sonoda; Daisuke Kukidome; Takahumi Senokuchi; Tomoko Matsuo; Takeshi Matsumura; Hiroshi Tokunaga; Michael Brownlee; Eiichi Araki
Journal:  Diabetes       Date:  2003-10       Impact factor: 9.461

6.  Tumor necrosis factor-alpha promotes macrophage-induced vascular smooth muscle cell apoptosis by direct and autocrine mechanisms.

Authors:  Joseph J Boyle; Peter L Weissberg; Martin R Bennett
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-07-17       Impact factor: 8.311

7.  The death ligand TRAIL in diabetic nephropathy.

Authors:  Corina Lorz; Alberto Benito-Martín; Anissa Boucherot; Alvaro C Ucero; Maria Pia Rastaldi; Anna Henger; Silvia Armelloni; Beatriz Santamaría; Celine C Berthier; Matthias Kretzler; Jesus Egido; Alberto Ortiz
Journal:  J Am Soc Nephrol       Date:  2008-02-20       Impact factor: 10.121

8.  Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis.

Authors:  S M Laster; J G Wood; L R Gooding
Journal:  J Immunol       Date:  1988-10-15       Impact factor: 5.422

Review 9.  The effect of pentoxifylline on proteinuria in diabetic kidney disease: a meta-analysis.

Authors:  Brendan B McCormick; Amy Sydor; Ayub Akbari; Dean Fergusson; Steve Doucette; Greg Knoll
Journal:  Am J Kidney Dis       Date:  2008-04-22       Impact factor: 8.860

10.  Induction of reactive oxygen species from isolated rat glomeruli by protein kinase C activation and TNF-alpha stimulation, and effects of a phosphodiesterase inhibitor.

Authors:  Nobuhiko Koike; Toshinari Takamura; Shuich Kaneko
Journal:  Life Sci       Date:  2007-02-09       Impact factor: 5.037

View more
  47 in total

1.  Anti-inflammatory and Antioxidative Activities of Safranal in the Reduction of Renal Dysfunction and Damage that Occur in Diabetic Nephropathy.

Authors:  Ömer Hazman; Mehmet Fatih Bozkurt
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

Review 2.  Impact of bariatric surgery on cardiovascular and renal complications of diabetes: a focus on clinical outcomes and putative mechanisms.

Authors:  William P Martin; Neil G Docherty; Carel W Le Roux
Journal:  Expert Rev Endocrinol Metab       Date:  2018-09-19

3.  Increased circulating cytokine levels in African American women with obesity and elevated HbA1c.

Authors:  Ariel Williams; Natasha Greene; K Kimbro
Journal:  Cytokine       Date:  2020-01-28       Impact factor: 3.861

Review 4.  Management of glycemia in diabetic patients with stage IV and V chronic kidney disease.

Authors:  Andrea Roche-Recinos; Esti Charlap; Mariana Markell
Journal:  Curr Diab Rep       Date:  2015-05       Impact factor: 4.810

5.  Galaxaura elongata Extract (GE) Modulates Vanadyl Sulfate-Induced Renal Damage via Regulating TGF-β/Smads and Nrf2/NF-κB Pathways.

Authors:  Al Khansaa A Kamel; Walaa Hozayen; Samraa H Abd El-Kawi; Khalid S Hashem
Journal:  Biol Trace Elem Res       Date:  2021-09-17       Impact factor: 3.738

6.  Involvement of the NF-κB signaling pathway in the renoprotective effects of isorhamnetin in a type 2 diabetic rat model.

Authors:  Shujuan Qiu; Guiling Sun; Yunxia Zhang; Xiangling Li; Rong Wang
Journal:  Biomed Rep       Date:  2016-03-22

7.  Effects of a GSK-3β inhibitor on the renal expression levels of RANK, RANKL and NF-κB in a rat model of diabetic nephropathy.

Authors:  Yi-Xia Zhou; Li-Xin Shi; Hua Yang; Yi-Guo Long; L U Meng; Li-Sa Lv; Yang Zhang; Huan Yao; Long Li; Yan-Ni Yu
Journal:  Exp Ther Med       Date:  2016-03-24       Impact factor: 2.447

8.  The correlation between blood oxidative stress and sialic acid content in diabetic patients with nephropathy, hypertension, and hyperlipidemia.

Authors:  Sedigheh Shahvali; Armita Shahesmaeili; Mojgan Sanjari; Somayyeh Karami-Mohajeri
Journal:  Diabetol Int       Date:  2019-05-09

9.  FK506 ameliorates podocyte injury in type 2 diabetic nephropathy by down-regulating TRPC6 and NFAT expression.

Authors:  Ruixia Ma; Liqiu Liu; Wei Jiang; Yanjuan Yu; Haifeng Song
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

10.  Results from the Effects of MEtformin on cardiovasculaR function in AdoLescents with type 1 Diabetes (EMERALD) study: A brief report of kidney and inflammatory outcomes.

Authors:  Kalie L Tommerdahl; Petter Bjornstad; Jessica Kendrick; Melanie Cree-Green; Amy D Baumgartner; Laura Pyle; Jane E B Reusch; Kristen J Nadeau
Journal:  Diabetes Obes Metab       Date:  2020-12-23       Impact factor: 6.577

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.